214 related articles for article (PubMed ID: 24763308)
1. Longer telomere length in COPD patients with α1-antitrypsin deficiency independent of lung function.
Saferali A; Lee J; Sin DD; Rouhani FN; Brantly ML; Sandford AJ
PLoS One; 2014; 9(4):e95600. PubMed ID: 24763308
[TBL] [Abstract][Full Text] [Related]
2. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
[TBL] [Abstract][Full Text] [Related]
3. Accelerated telomere attrition in children and teenagers with α1-antitrypsin deficiency.
Escribano A; Pastor S; Reula A; Castillo S; Vicente S; Sanz F; Casas F; Torres M; Fernández-Fabrellas E; Codoñer-Franch P; Dasí F
Eur Respir J; 2016 Aug; 48(2):350-8. PubMed ID: 27390278
[TBL] [Abstract][Full Text] [Related]
4. Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD.
Vijayasaratha K; Stockley RA
Int J Chron Obstruct Pulmon Dis; 2012; 7():789-96. PubMed ID: 23226015
[TBL] [Abstract][Full Text] [Related]
5. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.
Demeo DL; Campbell EJ; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard SI; Sandhaus RA; Stocks JM; Stoller JK; Strange C; Turino G; Silverman EK
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):114-20. PubMed ID: 17690329
[TBL] [Abstract][Full Text] [Related]
6. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
[TBL] [Abstract][Full Text] [Related]
7. COPD: new lessons from alpha1-antitrypsin deficiency?
Wanner A
Chest; 2009 May; 135(5):1342-1344. PubMed ID: 19420201
[No Abstract] [Full Text] [Related]
8. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
Stockley RA; Edgar RG; Pillai A; Turner AM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
[TBL] [Abstract][Full Text] [Related]
9. Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD.
Rodriguez F; de la Roza C; Jardi R; Schaper M; Vidal R; Miravitlles M
Chest; 2005 May; 127(5):1537-43. PubMed ID: 15888825
[TBL] [Abstract][Full Text] [Related]
10. Function of monocytes and monocyte-derived macrophages in α1-antitrypsin deficiency.
Van't Wout EF; van Schadewijk A; Lomas DA; Stolk J; Marciniak SJ; Hiemstra PS
Eur Respir J; 2015 Feb; 45(2):365-76. PubMed ID: 25323228
[TBL] [Abstract][Full Text] [Related]
11. SERPINA1 11478G→A variant, serum α1-antitrypsin, exacerbation frequency and FEV1 decline in COPD.
Quint JK; Donaldson GC; Kumari M; Talmud PJ; Hurst JR
Thorax; 2011 May; 66(5):418-24. PubMed ID: 21335450
[TBL] [Abstract][Full Text] [Related]
12. Shortened telomere length in peripheral blood leukocytes of patients with lung cancer, chronic obstructive pulmonary disease in a high indoor air pollution region in China.
Xue Y; Guo X; Huang X; Zhu Z; Chen M; Chu J; Yang G; Wang Q; Kong X
Mutat Res Genet Toxicol Environ Mutagen; 2020; 858-860():503250. PubMed ID: 33198931
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
[TBL] [Abstract][Full Text] [Related]
14. Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease.
Mahadeva R; Westerbeek RC; Perry DJ; Lovegrove JU; Whitehouse DB; Carroll NR; Ross-Russell RI; Webb AK; Bilton D; Lomas DA
Eur Respir J; 1998 Apr; 11(4):873-9. PubMed ID: 9623690
[TBL] [Abstract][Full Text] [Related]
15. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
[TBL] [Abstract][Full Text] [Related]
16. Alpha one antitrypsin deficiency: from gene to treatment.
Wood AM; Stockley RA
Respiration; 2007; 74(5):481-92. PubMed ID: 17671403
[TBL] [Abstract][Full Text] [Related]
17. Performance of the BODE index in patients with α1-antitrypsin deficiency-related COPD.
Thabut G; Mornex JF; Pison C; Cuvelier A; Balduyck M; Pujazon MC; Fournier M; AitIlalne B; Porcher R
Eur Respir J; 2014 Jul; 44(1):78-86. PubMed ID: 24525449
[TBL] [Abstract][Full Text] [Related]
18. DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease.
Birch J; Anderson RK; Correia-Melo C; Jurk D; Hewitt G; Marques FM; Green NJ; Moisey E; Birrell MA; Belvisi MG; Black F; Taylor JJ; Fisher AJ; De Soyza A; Passos JF
Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1124-37. PubMed ID: 26386121
[TBL] [Abstract][Full Text] [Related]
19. α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.
Sørheim IC; Bakke P; Gulsvik A; Pillai SG; Johannessen A; Gaarder PI; Campbell EJ; Agustí A; Calverley PM; Donner CF; Make BJ; Rennard SI; Vestbo J; Wouters EF; Paré PD; Levy RD; Coxson HO; Lomas DA; Hersh CP; Silverman EK
Chest; 2010 Nov; 138(5):1125-32. PubMed ID: 20595457
[TBL] [Abstract][Full Text] [Related]
20. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
